BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 25121962)

  • 1. Strongyloidiasis--an insight into its global prevalence and management.
    Puthiyakunnon S; Boddu S; Li Y; Zhou X; Wang C; Li J; Chen X
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3018. PubMed ID: 25121962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strongyloidiasis with emphasis on human infections and its different clinical forms.
    Toledo R; Muñoz-Antoli C; Esteban JG
    Adv Parasitol; 2015 Apr; 88():165-241. PubMed ID: 25911368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strongyloides stercoralis in the Immunocompromised Population.
    Keiser PB; Nutman TB
    Clin Microbiol Rev; 2004 Jan; 17(1):208-17. PubMed ID: 14726461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human infection with Strongyloides stercoralis and other related Strongyloides species.
    Nutman TB
    Parasitology; 2017 Mar; 144(3):263-273. PubMed ID: 27181117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection.
    Segarra-Newnham M
    Ann Pharmacother; 2007 Dec; 41(12):1992-2001. PubMed ID: 17940124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CATMAT statement on disseminated strongyloidiasis: Prevention, assessment and management guidelines.
    Boggild AK; Libman M; Greenaway C; McCarthy AE; ;
    Can Commun Dis Rep; 2016 Jan; 42(1):12-19. PubMed ID: 29769976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strongyloides stercoralis: risks posed to immigrant patients in an Australian tertiary referral centre.
    Einsiedel L; Spelman D
    Intern Med J; 2006 Oct; 36(10):632-7. PubMed ID: 16958639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of severe strongyloidiasis attended at reference centers in Spain.
    Martinez-Perez A; Roure Díez S; Belhassen-Garcia M; Torrús-Tendero D; Perez-Arellano JL; Cabezas T; Soler C; Díaz-Menéndez M; Navarro M; Treviño B; Salvador F;
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006272. PubMed ID: 29474356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
    Carvalho EM; Da Fonseca Porto A
    Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal strongyloidiasis and hyperinfection syndrome.
    Vadlamudi RS; Chi DS; Krishnaswamy G
    Clin Mol Allergy; 2006 May; 4():8. PubMed ID: 16734908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overwhelming strongyloidiasis: an unappreciated opportunistic infection.
    Scowden EB; Schaffner W; Stone WJ
    Medicine (Baltimore); 1978 Nov; 57(6):527-44. PubMed ID: 362122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strongyloidiasis-related lung involvement: too much of a bad thing.
    Barkati S; Greenaway C; Libman M
    Curr Opin Infect Dis; 2023 Jun; 36(3):203-208. PubMed ID: 37093059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a rapid serological assay for the diagnosis of strongyloidiasis using a novel diffraction-based biosensor technology.
    Pak BJ; Vasquez-Camargo F; Kalinichenko E; Chiodini PL; Nutman TB; Tanowitz HB; McAuliffe I; Wilkins P; Smith PT; Ward BJ; Libman MD; Ndao M
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3002. PubMed ID: 25102174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of Strongyloides stercoralis infection.
    Siddiqui AA; Berk SL
    Clin Infect Dis; 2001 Oct; 33(7):1040-7. PubMed ID: 11528578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of real-time PCR for the detection of Strongyloides spp. in clinical samples in a reference center in Spain.
    Saugar JM; Merino FJ; Martín-Rabadán P; Fernández-Soto P; Ortega S; Gárate T; Rodríguez E
    Acta Trop; 2015 Feb; 142():20-5. PubMed ID: 25447829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strongyloides stercoralis infection complicating the central nervous system.
    Woll F; Gotuzzo E; Montes M
    Handb Clin Neurol; 2013; 114():229-34. PubMed ID: 23829913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strongyloides stercoralis, the hidden worm. Epidemiological and clinical characteristics of 70 cases diagnosed in the North Metropolitan Area of Barcelona, Spain, 2003-2012.
    Valerio L; Roure S; Fernández-Rivas G; Basile L; Martínez-Cuevas O; Ballesteros ÁL; Ramos X; Sabrià M;
    Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):465-70. PubMed ID: 23783760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strongyloides stercoralis infection: A systematic review of endemic cases in Spain.
    Barroso M; Salvador F; Sánchez-Montalvá A; Bosch-Nicolau P; Molina I
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007230. PubMed ID: 30860995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
    Ashida C; Kinoshita K; Nozaki Y; Funauchi M
    BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strongyloides stercoralis in solid organ transplantation: early diagnosis gets the worm.
    Mobley CM; Dhala A; Ghobrial RM
    Curr Opin Organ Transplant; 2017 Aug; 22(4):336-344. PubMed ID: 28562417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.